학술논문
Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study
Document Type
Article
Author
Source
In The American Journal of Geriatric Psychiatry May 2022 30(5):541-556
Subject
Language
ISSN
1064-7481